First question: Does CRT Work in AF?

Size: px
Start display at page:

Download "First question: Does CRT Work in AF?"

Transcription

1 CRT in AF Does it work and when to ablate AF versus AV node Maurizio Gasparini Chief EP and Pacing Unit Humanitas Research Hospital, Rozzano - Milano, Italy

2 First question: Does CRT Work in AF? As any machine If optimal working CRT is expected! you need optimal settings and conditions Whitout fuel Even a Ferrari cannot work

3 Guidelines requires optimal medical therapy in HF, e. the maximum tolerate dosage!! Could you consider OPT the prescription of carvedilol.25 mg ¼ tablet b.i.d.?! In the same way, to cure HF with CRT, we should hieve maximum biventricular pacing (i.e. 100%)!! To achieve 100% BIV pacing 1) in SR pts Would CRT be effective in SR + AV delay of 300 msec?! natural AV conduction! no BIV pacing! no CRT 2) in AF pts?!

4 AF and CRT (problems for CRT delivery)! intrinsic, irregular spontaneous ventricular rhythm " % of effectively BIV paced captured beats;! during effort, reduced % of BIV pacing;! interference of fusion or pseudo-fusion beats Surface ECG Atrial EGM RV EGM Biventricular pacing! possible negative impact on prognosis of using negative chronotropic therapy.

5 So does CRT Work in persistent / permanent AF? JACC 2006 JACC 2006 # Due to lack of RCTs, European GL based on several observational studies concerning CRT-AF pts in the last yrs

6 JACC subgroup of RCT (MUSTIC 2002) 4 prospective cohort studies 1164 pts 797 SR 367 AF SR vs AF

7 # Finally in 2012 a RCT 1798 patients 229 AF randomized to ICD or CRT-D CRT-D (n =114) ICD (n =115) AF CRT-D AF ICD

8 # No difference in primary outcome of death or HF hospitalization # Borderline HF hosp in CRT versus ICD # No effect on mortality rate

9 1) RAFT trial not designed to evaluate CRT effect in AF pts 2) 3) Only 1/3 of AF pt had BIV pacing more than 95% time

10 Conceptual difference between simply implant a CRT device in AF patients and cure AF patients with CRT. As previously reported BIV pacing % may be compared to OPT! maximized drug therapy! 100% BIV pacing desirable In RAFT, AF pts RECEIVED CRT! NOT ADEQUATE WORKING CONDITIONS and were not cured with CRT

11 D Hayes Perfect (complete) BIV delivery Ineffective BIV delivery good (acceptable) BIV delivery Less than 5% difference of BIV pacing determine a significative difference in mortality (10% gain) pts 2yrs f.u.

12 Circ Arrhythm Electrophysiol June 2014

13 Circ Arrhythm Electrophysiol June 2014

14 # After RAFT trial. And considering that 1) DIFFERENCE BETWEEN THE ABSENCE OF POSITIVE TRIAL 2) And DENIED POSSIBILITY OF PERFORMING RCTs back to several observational studies and metanalysis to evaluate CRT in AF pts.

15 Total pts 1873 AF pts 245 pts AF + CRT + drugs vs AF + CRT + AVJ ablation

16 AF pts 369 pts

17

18 This concept confirmed by.! 7384 pts SR : 6046 pts. AF : 1338 pts AF AVJA! 443 pts AF drugs! 895 pts

19 person'year person,year mean,fup mean'follow.up'(months) COMPANION, CARE,HF REVERSE MADIT,CRT RAFT, NOI CERTIFY : person/year: 10-fold higher than all randomized trials of CRT put together!!! JACC HF 2013

20 Results EF 40% 35% 30% 25% 20% 15% 10% 5% 0% Echo results $ LVEF in $ AF LVEF + AVJA at 6 and months SR higher in all 3 than groups AF + drugs P<0.003 P<0.001 BASE 6M BASE 6M BASE 6M Gasparini et al JACC HF 2013 SR AF+ DRUGS AF+AVJA

21 Gasparini et al JACC HF 2013 Results Echo results - Reverse remodelling groups : " LVESV at 6 months (all p<0.001) no further " after 6 months in AF+ drugs! ESV ml Continuous " LVESV months SR AF+drugs AF+AVJA

22 Results 6.8%/yrs 6.1%/yrs 11.3%/yrs Gasparini et al JACC HF 2013

23 Results 6.8%/yrs 4.2%/yrs 6.1%/yrs 4.0%/yrs 11.3%/yrs 8.1%/yrs Gasparini et al JACC HF 2013

24 Multivariable analysis Gasparini et al JACC HF 2013 HR 1.52 HR 0.93 HR 1.57 HR 0.88

25 Back to 1 st question: does CRT Work in AF? YES, IT DOES!!!! if 100% BIV achieved! usually possible with AVNJ ablation only Pre abl Post abl VP 100%

26 Second question: when to ablate AF versus AV node Could CRT pts be ideal candidates for PV isolation?! pts with LV recovery and parallel LA remodelling?! paroxysmal AF after CRT usually well controlled...! Even in persistent and permanent AF! CRT may allow SINUS RHYTHM RESUMPTION

27 CRT & AF: sinus rhythm resumption 330 pts permanent AF + CRT! 34 (10%) SRR at a median 4 mos f.u. At the multivariate analysis SRR was associated to! post CRT QRS < 150 ms! baseline EDD < 65 mm! LA diameter < 50 mm! AV junction ablation Pts with HF and permanent AF may restore SR

28 And back to clinical experience After SR resumption, stable SR (usually no need for PV isolation) SR Resumption Stable SR

29 Concerning AV node ablation.. Do not forget Not only 100% BIV warrented. Abolition of inappropriate shocks on rapid AF Risk of AF recurrences with PV isolation and inappropriate shocks

30 HF + AF: Is the correct 2 nd question PV ablation or CRT+ AVJ ablation??? Upstream decision..

31 Ablation for AF in patients with HF Or? Which has to be treated first? How to evaluate an AF + HF pt? Different scenarios are possible Which came first? The chicken / egg dilemma AF or HF?

32 AF driving HF! Usually not very enlarged LA! Moderately depressed LVEF (40-45%)! Paroxysmal AF/ Persistent AF! ~ EF in SR! "" EF during AF TACHICARDIOMIOPATHY - FIRST CHOICE AF ABLATION AF and HF Upstream decision.. HF driving AF! Usually enlarged LA- LV (complex substrate-fibrosis)! depressed LVEF (< 30-35%)! Persistent AF/Permanent AF! Previous failed RF attempts Failed Electr CV! LV vol! secondary MVR LA volume! permanent AF CARDIOMIOPATHY - FIRST CHOICE CRT-D

33 % Randomized trial on AF pts with CHF: PV Antrum Isolation vs AVJ abl + CRT 41 pts PVI and 40 pts CRT+ AVJ ablation Mean follow up : 6 months

34 PABA CHF HF pts are not the conventional CRT pts! it is not possible to extend these results to all HF pts 1) PVI may be indicated in pts with PAROXYSMAL AF with MILD HF probably due to tachycardiomyopathy 2)...since in patients with refractory HF despite OPT and PERMANENT AF, CRT is now recommended (class IIa)

35 Second question: when to ablate AF versus AV node In clinical practice pts with CRT-D are prone to peristent/permanent AF more than Paroxysmal Indications to AV nodal ablation if inadequate BIV pacing

36 Conclusions! 1 st question: does CRT in AF works?,! Yes, it works!! only if 100% BIV pacing is obtained! in permanent AF usually possible by AVJ ablation only! After CRT + AVJ ablation, sinus rhythm resumption is possible in up to 10-15% of pts! 2 nd question : The choice between PV isolation and AV node ablation (after CRT) should be an UPSTREAM DECISION (not after CRT )

Bi-Ventricular pacing after the most recent studies

Bi-Ventricular pacing after the most recent studies Seminars of the Hellenic Working Groups February 18th-20 20,, 2010, Thessaloniki, Greece Bi-Ventricular pacing after the most recent studies Maurizio Lunati MD Director EP Lab & Unit Cardiology Dpt. Niguarda

More information

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Alessandria, September 23 th 2017 Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Professor Fiorenzo Gaita Chief of the Cardiovascular Department Città della Salute e della Scienza

More information

CRT response: definition and handling of non-responders

CRT response: definition and handling of non-responders CRT response: definition and handling of non-responders Maurizio Gasparini Chief of Electrophysiology and Pacing Unit IRCCS, Istituto Clinico Humanitas, Rozzano- Italy Definition of non-responders First

More information

Interventional solutions for atrial fibrillation in patients with heart failure

Interventional solutions for atrial fibrillation in patients with heart failure Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department

More information

Importance of CRT team for optimization of the results: a European point of view

Importance of CRT team for optimization of the results: a European point of view Importance of CRT team for optimization of the results: a European point of view Matteo Bertini, MD, PhD Arcispedale S. Anna Azienda Ospedaliero-Universitaria Cona-Ferrara No conflict of interest to declare

More information

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Management of Atrial Fibrillation in Heart Failure

Management of Atrial Fibrillation in Heart Failure Management of Atrial Fibrillation in Heart Failure Hani Sabbour MD FACC FHRS FASE Clinical Assistant Professor of Cardiology Brown University, Warren Alpert School of Medicine Rhode Island, USA Consultant

More information

Catheter ablation in AF patients with heart failure. What is possible?

Catheter ablation in AF patients with heart failure. What is possible? Catheter ablation in AF patients with heart failure What is possible? Sébastien Knecht, MD PhD Hôpital cardiologique du Haut L Evêque, Bordeaux HEART FAILURE AND AF Ehrlich. JCE 2002 (13): 399-405, Wang

More information

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita Scompenso cardiaco e F A : ruolo della ablazione transcatetere Prof. Fiorenzo Gaita Patients with atrial fibrillation (%) Prevalence of AF in HF Trials 60 50 30% NYHA III-IV NYHA IV 40 NYHA II-III 30 20

More information

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Devices and Other Non- Pharmacologic Therapy in CHF Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Disclosure None University of Miami vs. OSU Renegade Miami football

More information

How atrial fibrillation should be treated in the heart failure patient?

How atrial fibrillation should be treated in the heart failure patient? Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 13/15 Ottobre 2016 How atrial fibrillation should be treated in the heart failure patient? Matteo Anselmino Dipartimento Scienze

More information

Cardiac Resynchronization ICD Therapy: What is New?

Cardiac Resynchronization ICD Therapy: What is New? Cardiac Resynchronization ICD Therapy: What is New? Emile Daoud, MD Section Chief, Cardiac Electrophysiology Professor of Medicine The Ohio State University Normal Activation, Narrow QRS Synchrony Abnormal

More information

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Philippe Mabo University Hospital, Rennes, France ESC Congress 2010, Stockholm 29 Aug 2010 Which Patients? Candidate for

More information

HF and CRT: CRT-P versus CRT-D

HF and CRT: CRT-P versus CRT-D HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA

More information

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation ANIL K. BHANDARI, M.D, Director, Electrophysiology and EPS Fellowship Program Good Samaritan Hospital/ Harbor UCLA

More information

Tehran Arrhythmia Center

Tehran Arrhythmia Center Tehran Arrhythmia Center The Worst Scenario A 4 year old kid High heart rates first noted by parents at 20 months of age. Family physician detected rates as high as 220 bpm at that age. He was visited,

More information

How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation?

How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation? How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation? Thang Nguyen MD FRCPC Assistant Professor Section of Cardiology Department of Internal Medicine University of Manitoba Objectives

More information

This is What I do to Improve CRT Response for CRT Non-Responders

This is What I do to Improve CRT Response for CRT Non-Responders This is What I do to Improve CRT Response for CRT Non-Responders Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Steering Committees (unpaid) and Clinical Trials,

More information

Role of Ablation of AF and PVCs in the Management of Heart Failure

Role of Ablation of AF and PVCs in the Management of Heart Failure Role of Ablation of AF and PVCs in the Management of Heart Failure Cara Pellegrini, MD, FHRS Acting Chief, Cardiology, SF VA Associate Professor of Medicine, UCSF Disclosures I have nothing to disclose

More information

Cardiac Resynchronization Therapy. Michelle Khoo, MD

Cardiac Resynchronization Therapy. Michelle Khoo, MD Cardiac Resynchronization Therapy Michelle Khoo, MD 10.7.08 HuiKuri HV NEJM 2001 Sudden Death (SD) in Subset Populations HuiKuri HV NEJM 2001 Sudden Death (SD) in Subset Populations SD in Competitive Athletes

More information

The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy

The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy Results from the SMART-AV Trial Michael R. Gold, MD, PhD, Ulrika Birgersdotter-Green,

More information

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for

More information

His Bundle Pacing in Bundle Branch Block May 11, 2017

His Bundle Pacing in Bundle Branch Block May 11, 2017 His Bundle Pacing in Bundle Branch Block May 11, 2017 Gopi Dandamudi, MD FHRS System Medical Director, IUH Cardiac EP Program Director, IUH Atrial Fibrillation Center Assistant Professor of Clinical Medicine

More information

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J. Saving Lives and Preventing Heart Failure: The MADIT Family of Trials Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Update in Electrocardiography

More information

CRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT?

CRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT? CRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT? Alessandro Lipari, MD Chair and Department of Cardiology University of Study and Spedali Civili Brescia -Italy The birth of CRT in Europe, 20 years ago

More information

DON T FORGET TO OPTIMISE DEVICE PROGRAMMING

DON T FORGET TO OPTIMISE DEVICE PROGRAMMING CRT:NON-RESPONDERS OR NON-PROGRESSORS? DON T FORGET TO OPTIMISE DEVICE PROGRAMMING Prof. ALİ OTO,MD,FESC,FACC,FHRS Chairman,Department of Cardiology Hacettepe University Faculty of Medicine,Ankara Causes

More information

Device based CRT optimization: is there a future? Lessons learned from published trials

Device based CRT optimization: is there a future? Lessons learned from published trials Device based CRT optimization: is there a future? Lessons learned from published trials C. Leclercq Department of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information

More information

Provocative Cases: Issues in the Expanding Use of CRT in Treating CHF Patients

Provocative Cases: Issues in the Expanding Use of CRT in Treating CHF Patients Provocative Cases: Issues in the Expanding Use of CRT in Treating CHF Patients David E. Krummen, MD Associate Professor of Medicine University of California San Diego and VA San Diego Healthcare System

More information

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese Because the primary objective was cure symptomatic bradicardya due to syncope Because this is the common

More information

Thoranis Chantrarat MD

Thoranis Chantrarat MD Device Therapy in Heart Failure Thoranis Chantrarat MD 1 Scope of presentation Natural history of heart failure Primary and secondary prevention ICD and its indication CRT and its indication 2 Severity

More information

Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή;

Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή; Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή; Άννα Κωστοπούλου Επιμελήτρια Α Ωνάσειο Καρδιοχειρουργικό Κέντρο Τμήμα Ηλεκτροφυσιολογίας

More information

BSH Annual Autumn Meeting 2017

BSH Annual Autumn Meeting 2017 BSH Annual Autumn Meeting 2017 Presentation title: The Development of CRT Speaker: John GF Cleland Conflicts of interest: I have received research support and honoraria from Biotronik, Boston Scientific,

More information

Cardiac Resynchronization Therapy for Heart Failure

Cardiac Resynchronization Therapy for Heart Failure Cardiac Resynchronization Therapy for Heart Failure Ventricular Dyssynchrony vs Resynchronization Ventricular Dysynchrony Ventricular Dysynchrony 1 Electrical: Inter- or Intraventricular conduction delays

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Treatment of Atrial Fibrillation in Heart Failure

Treatment of Atrial Fibrillation in Heart Failure Stockholm, September 1st 2010 Treatment of Atrial Fibrillation in Heart Failure Rhythm control: Which drugs? Stefan H. Hohnloser J.W. Goethe University Frankfurt, Germany Presenter disclosure information:

More information

BENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT

BENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT BENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT Ilan Goldenberg MD Professor of Cardiology Sheba Medical Center and Tel Aviv University, Israel University of Rochester

More information

Left Ventricular Ejection Fraction >35%

Left Ventricular Ejection Fraction >35% Controversies in Cardiac Resynchronisation Therapy Left Ventricular Ejection Fraction >35% Professor John GF Cleland University of Hull Kingston-upon-Hull United Kingdom Conflict of Interest: I have received

More information

Medical management of AF: drugs for rate and rhythm control

Medical management of AF: drugs for rate and rhythm control Medical management of AF: drugs for rate and rhythm control Adel Khalifa Sultan Hamad, BMS, MD, FGHRS, FRCP(Canada) Consultant Cardiologist & Interventional Cardiac Electrophysiologist Head of Electrophysiology

More information

Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα

Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα 2015-2016 Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος Dr. Konstantinou has received

More information

Cardiac Resynchronization Therapy Guidelines and Missing Groups

Cardiac Resynchronization Therapy Guidelines and Missing Groups Cardiac Resynchronization Therapy Guidelines and Missing Groups Frank Pelosi, Jr., MD, FACC, FHRS Director, Cardiac Electrophysiology Fellowship Associate Professor of Medicine University of Michigan Health

More information

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Walid Saliba, MD, FHRS Director, Atrial Fibrillation Center Director EP laboratory Heart and Vascular Institute Cleveland

More information

ICD Guidelines: who benefits from an ICD?

ICD Guidelines: who benefits from an ICD? ICD Guidelines: who benefits from an ICD? Matthew Bennett Cardiac Electrophysiologist Vancouver Coastal Health, Device Lead Associate Professor, UBC Matthew.bennett@vch.ca Disclosures I have research collaborations

More information

Rate vs. Rhythm Control in Atrial Fibrillation

Rate vs. Rhythm Control in Atrial Fibrillation Rate vs. Rhythm Control in Atrial Fibrillation Recent Perspectives Saeed Oraii MD Electrophysiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic Delirium Cordis First described by Sir

More information

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention

More information

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we

More information

La stimulation biventriculaire (Traitement par Resynchronisation Cardiaque) Indications et Résultats. Daniel Gras, DIU, Paris 2007

La stimulation biventriculaire (Traitement par Resynchronisation Cardiaque) Indications et Résultats. Daniel Gras, DIU, Paris 2007 La stimulation biventriculaire (Traitement par Resynchronisation Cardiaque) Indications et Résultats, DIU, Paris 2007 CRT: Results and indications Background Results of CRT Studies Today s classical CRT

More information

CRT in the RV Paced Patient When to Upgrade?

CRT in the RV Paced Patient When to Upgrade? Ben Gurion University CRT in the RV Paced Patient When to Upgrade? I. Eli Ovsyshcher, MD, PhD, FESC, FACC, FHRS, FA Professor of Medicine/Cardiology Ben Gurion University of the Negev Beer-Sheva, Israel

More information

The Role of ICD Therapy in Cardiac Resynchronization

The Role of ICD Therapy in Cardiac Resynchronization The Role of ICD Therapy in Cardiac Resynchronization The Korean Society of Circulation 15 April 2005 Angel R. León, MD Carlyle Fraser Heart Center Division of Cardiology Emory University School of Medicine

More information

Cardiac resynchronization therapy for heart failure: state of the art

Cardiac resynchronization therapy for heart failure: state of the art Cardiac resynchronization therapy for heart failure: state of the art Béla Merkely MD, PhD, DSc, FESC, FACC Vice president of the European Society of Cardiology Honorary president of the Hungarian Society

More information

How to Maximize CRT Response?

How to Maximize CRT Response? How to Maximize CRT Response? Chu-Pak Lau, MD Honorary Clinical Professor Department of Medicine University of Hong Kong Queen Mary Hospital Hong Kong 1 100% 1/3 of Patients Are Non-Responders of CRT 90%

More information

Ventricular Arrhythmias

Ventricular Arrhythmias Presenting your most challenging cases Venice Arrhythmias Ventricular Arrhythmias Gioia Turitto, MD Presenter Disclosure Information A questionable indication for CRT-D in a patient with VT after successful

More information

Atrial fibrillation and advanced age

Atrial fibrillation and advanced age Atrial fibrillation and advanced age Prof. Fiorenzo Gaita Director of the Cardiology School University of Turin, Italy Prevalence of AF in the general population Prevalence and age distribution in patients

More information

Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation?

Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation? 1 Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation? Chu-Pak Lau, MD Honorary Clinical Professor Queen Mary Hospital The University of Hong Kong How to Prevent AF by Pacing 1.

More information

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy Electrophysiology Gender and cardiac resynchronization therapy Dean Boddington Chairs: David Heaven & Belinda Green Gender and Cardiac Resynchronisation Therapy Dean Boddington Tauranga Hospital 1 Disclosure/Warning

More information

Reducing unnecessary and inappropriate therapy in secondary prevention patients

Reducing unnecessary and inappropriate therapy in secondary prevention patients Reducing unnecessary and inappropriate therapy in secondary prevention patients Maurizio Gasparini, MD Chief of EP and Pacing Unit Humanitas Research Hospital, Rozzano-Milano Italy Goals of Optimal ICD

More information

Differential diagnosis and pacing in maneuvers narrow QRS tachycardia. Richard Schilling

Differential diagnosis and pacing in maneuvers narrow QRS tachycardia. Richard Schilling Differential diagnosis and pacing in maneuvers narrow QRS tachycardia Richard Schilling Differential diagnosis of narrow complex QRS tachycardia Anything that activates the ventricle normally via the His

More information

Tachycardia Devices Indications and Basic Trouble Shooting

Tachycardia Devices Indications and Basic Trouble Shooting Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and

More information

Rate and Rhythm Control of Atrial Fibrillation

Rate and Rhythm Control of Atrial Fibrillation Rate and Rhythm Control of Atrial Fibrillation April 21, 2017 춘계심혈관통합학술대회 Jaemin Shim, MD, PhD Arrhythmia Center Korea University Anam Hospital Treatment of AF Goal Reducing symptoms Preventing complication

More information

ESC/EHRA. Guidelines on Cardiac Pacing. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece

ESC/EHRA. Guidelines on Cardiac Pacing. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece ESC/EHRA Guidelines on Cardiac Pacing Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece Reasons for European Guidelines? Scientific reasons Cultural and political reasons

More information

How to Approach the Patient with CRT and Recurrent Heart Failure

How to Approach the Patient with CRT and Recurrent Heart Failure How to Approach the Patient with CRT and Recurrent Heart Failure Byron K. Lee MD Associate Professor of Medicine Electrophysiology and Arrhythmia Section UCSF Update in Electrocardiography and Arrhythmias

More information

La gestione di un paziente con ICD: come evitare gli shock inappropriati e prolungare la sopravvivenza del paziente. Maurizio Gasparini

La gestione di un paziente con ICD: come evitare gli shock inappropriati e prolungare la sopravvivenza del paziente. Maurizio Gasparini La gestione di un paziente con ICD: come evitare gli shock inappropriati e prolungare la sopravvivenza del paziente Maurizio Gasparini Responsabile UO Elettrofisiologia ed Elettrostimolazione Humanitas

More information

Effect of Ventricular Pacing on Myocardial Function. Inha University Hospital Sung-Hee Shin

Effect of Ventricular Pacing on Myocardial Function. Inha University Hospital Sung-Hee Shin Effect of Ventricular Pacing on Myocardial Function Inha University Hospital Sung-Hee Shin Contents 1. The effect of right ventricular apical pacing 2. Strategies for physiologically optimal ventricular

More information

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Need to Know: Implantable Devices Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Disclosure Statement I have no relationships to disclose. Objectives Discuss the most

More information

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER ICD for NICM All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, 2017 2017 MFMER 3686275-1 DISCLOSURE Relevant Financial Relationship(s)

More information

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor

More information

Everything you need to know about His bundle pacing October 20, 2017

Everything you need to know about His bundle pacing October 20, 2017 Everything you need to know about His bundle pacing October 20, 2017 Gopi Dandamudi, MD FHRS System Medical Director, IUH Cardiac Electrophysiology Program Director, IUH Atrial Fibrillation Center Assistant

More information

Managing Atrial Fibrillation in the Heart Failure Patient

Managing Atrial Fibrillation in the Heart Failure Patient Managing Atrial Fibrillation in the Heart Failure Patient Jonathan S. Steinberg, MD Professor of Medicine (adj) University of Rochester School of Medicine & Dentistry Director, Arrhythmia Institute Valley

More information

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On? The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On? L. Pison, MD PhD FESC AATS Surgical Treatment of Arrhythmias and Rhythm Disorders November 17-18, 2017 Miami Beach, FL, USA

More information

علم االنسان ما لم يعلم

علم االنسان ما لم يعلم In the name of Allah, the Beneficiate, the Merciful ق ال هللا تعالي: 5 الدى علم بالق لم 4 علم االنسان ما لم يعلم سورة العلق It is He (Allah), Who has taught by the pen He has taught man which he did not

More information

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev עדכונים באלקטרופיזיולוגיה 2014 Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev 1 מבנה הצגת היחידה פעילות ביחידה סקירה על הטיפול באלקטרופיזיולוגיה

More information

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Do All Patients With An ICD Indication Need A BiV Pacing Device? Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use? Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use? Helmut Pürerfellner, MD, Assoc. Prof. Saint Elisabeth s Sisters Hospital Academic Teaching Center Linz/Austria

More information

Heart Failure and Atrial Fibrillation. Stephen Wilton ACC Rockies Banff March 15, 2016

Heart Failure and Atrial Fibrillation. Stephen Wilton ACC Rockies Banff March 15, 2016 Heart Failure and Atrial Fibrillation Stephen Wilton ACC Rockies Banff March 15, 2016 Disclosures Research funding: St. Jude Medical Consulting / Honoraria Boehringer Ingelheim Arca Biopharma Key Points

More information

AF ABLATION Concepts and Techniques

AF ABLATION Concepts and Techniques AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications

More information

Inappropriate electrical shocks: Tackling the beast

Inappropriate electrical shocks: Tackling the beast ESC Paris 2011 Inappropriate electrical shocks: Tackling the beast Gerhard Hindricks University of Leipzig Heart Center Dept. of Electrophysiology ESC Paris 2011 Inappropriate electrical shocks: Tackling

More information

Device therapy in heartfailure Update of the ESC guidelines. Karl Swedberg

Device therapy in heartfailure Update of the ESC guidelines. Karl Swedberg Device therapy in heartfailure Update of the ESC guidelines Karl Swedberg Professor of Medicine Department of emergency and cardiovascular medicine Sahlgrenska Academy University of Gothenburg, Sweden

More information

How do I convert my CRT Non Responder into Responder?

How do I convert my CRT Non Responder into Responder? How do I convert my CRT Non Responder into Responder? Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting Boston Scientific, Medtronic

More information

ABLATION OF CHRONIC AF

ABLATION OF CHRONIC AF ABLATION OF CHRONIC AF A PISAPIA ST JOSEPH HOSPITAL MARSEILLE MEET 2008 Atrial Fibrillation The most common significant heart rhythm disturbance Incidence increases with age and the development of structural

More information

Subclinical AF: Implications of device based episodes

Subclinical AF: Implications of device based episodes Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific

More information

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University

More information

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: Consulting and Clinical Trials Medtronic

More information

Large RCT s of CRT 2002 to present

Large RCT s of CRT 2002 to present Have We Expanded Our Use of CRT for Heart Failure Patients? Sana M. Al-Khatib, MD, MHS Associate Professor of Medicine Electrophysiology Section- Division of Cardiology Duke University Potential Conflicts

More information

Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure

Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure Edmund Keung, MD Clinical Chief, Cardiology Section San Francisco VAMC October 25, 2008 Presentation Outline

More information

Why do we need ECHO for CRT device optimization?

Why do we need ECHO for CRT device optimization? Why do we need ECHO for CRT device optimization? Prof.dr.sc. J. Separovic Hanzevacki Department of Cardiovascular Diseases, University Hospital Centre Zagreb School of medicine, University of Zagreb Zagreb,

More information

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 Disclosures Research grant: St. Jude medical Speaking: Boehringer-Ingelheim Consulting: Arca Biopharma Learning

More information

EBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA

EBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA Over 200,000 patients worldwide are estimated to receive a CRT device each year. However, limitations prevent some patients from benefiting. CHALLENGING PROCEDURE 5% implanted patients fail to have coronary

More information

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist Are Drugs Better? Drugs or ablation as first line treatment for AF? Dr Mauro Lencioni Consultant Cardiologist & Electrophysiologist The Philosophical Issue What do we mean by Better? Outcome measures Measurement

More information

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland Disclosures Research Grants: Biosense Webster, St. Jude, Bard, Endosense, Biotronik Speakers Honoraria: Biosense Webster, Endosense,

More information

ESC Guidelines. ESC Guidelines Update For internal training purpose. European Heart Journal, doi: /eurheart/ehn309

ESC Guidelines. ESC Guidelines Update For internal training purpose. European Heart Journal, doi: /eurheart/ehn309 ESC Guidelines Update 2008 ESC Guidelines Heart failure update 2008 For internal training purpose. 0 Agenda Introduction Classes of recommendations Level of evidence Treatment algorithm Changes to ESC

More information

CRT Vs RV Pacing Benefits

CRT Vs RV Pacing Benefits CRT-P & CRT-D Indications According to Guidelines are Guidelines Fully Adopted? Salama H. Omar M.D. Prof. Critical Care Medicine, Cairo University CRT Vs RV Pacing Benefits 1 Benefit of Upgrade CTR-P &

More information

What s new in my specialty?

What s new in my specialty? What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty

More information

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,

More information

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist 2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist Todays Objectives Atrial Fibrillation evaluation and treatment from an EP perspective Multimodal

More information

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ ΣΔΛΙΟ ΠΑΡΑΚΔΤΑÏΓΗ ΓΙΔΤΘΤΝΣΗ ΔΤ Α Καρδιολογική Κλινική ΑΠΘ, Νοζοκομείο ΑΧΕΠΑ, Θεζζαλονίκη NO CONFLICT OF INTEREST INTRODUCTION Sustained VT is an important cause

More information

Heart failure and sudden death

Heart failure and sudden death Heart failure and sudden death What did we learn so far from important ICD- and CRT trials? Helmut U. Klein M.D. University of Rochester Medical Center Heart Research Follow up Program Arrhythmic substrate

More information

Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI

Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI Device Interrogation- Pacemakers, ICD and Loop Recorders Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI Disclosures Consultant: Medtronic Speaker s Bureau: St. Jude Medical

More information

Upgrade to Resynchronization Therapy. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016

Upgrade to Resynchronization Therapy. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016 Upgrade to Resynchronization Therapy Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016 Event Free Survival (%) CRT Cardiac resynchronization therapy (CRT)

More information

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current

More information